A Retrospective international analysis of real-world utilisation and bleed rates in patients with Haemophilia B who switched to recombinant factor IX fusion protein
Latest Information Update: 28 Apr 2020
At a glance
- Drugs Albutrepenonacog alfa (Primary)
- Indications Haemophilia B
- Focus Therapeutic Use
- Sponsors CSL Behring
Most Recent Events
- 28 Apr 2020 New trial record
- 24 Apr 2020 Results published in the Advances in Therapy